合計 50 件の最近のインサイダー取引記録が記録されています Terns Pharmaceuticals, Inc. (TERN), 内訳は 32 件の買い および 15 件の売り. インサイダー買い総額は $14.84M インサイダー売り総額は $1.33M.
最近活動のある主要インサイダーには Kuriakose Emil, Burroughs Amy L., Fellows David A. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — TERN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-01 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
942 |
$52.75 |
$49.69K |
105,673 |
| 2026-03-16 |
Burroughs Amy L. |
Chief Executive Officer |
情報に基づく売り |
2,770 |
$47.30 |
$131.03K |
288,976 |
| 2026-02-17 |
Burroughs Amy L. |
Chief Executive Officer |
情報に基づく売り |
4,083 |
$39.80 |
$162.5K |
288,976 |
| 2026-02-01 |
Fellows David A |
Director |
RSU 付与（制限付株式） |
2,828 |
$34.60 |
$97.85K |
2,828 |
| 2026-02-01 |
Kindler Jeffrey B |
Director |
RSU 付与（制限付株式） |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Turner Heather D |
Director |
RSU 付与（制限付株式） |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Azelby Robert |
Director |
RSU 付与（制限付株式） |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Tripuraneni Radhika |
Director |
RSU 付与（制限付株式） |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Quigley Jill M. |
Director |
RSU 付与（制限付株式） |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-01-15 |
Burroughs Amy L. |
Chief Executive Officer |
情報に基づく売り |
7,521 |
$37.53 |
$282.23K |
288,976 |
| 2026-01-14 |
Gengos Andrew |
Chief Financial Officer |
RSU 付与（制限付株式） |
68,750 |
- |
- |
101,788 |
| 2026-01-14 |
Burroughs Amy L. |
Chief Executive Officer |
RSU 付与（制限付株式） |
150,000 |
- |
- |
288,976 |
| 2026-01-14 |
Kuriakose Emil |
Chief Medical Officer |
RSU 付与（制限付株式） |
56,250 |
- |
- |
106,615 |
| 2026-01-05 |
Burroughs Amy L. |
Chief Executive Officer |
オプション行使（売却） |
150,000 |
- |
- |
- |
| 2026-01-02 |
Burroughs Amy L. |
Chief Executive Officer |
オプション行使 |
21,551 |
$4.64 |
$100K |
60,315 |
| 2026-01-02 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
955 |
$38.36 |
$36.63K |
50,365 |
| 2025-11-04 |
Quigley Jill M. |
Director |
情報に基づく売り |
24,520 |
$18.00 |
$441.36K |
- |
| 2025-10-01 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
944 |
$7.85 |
$7.41K |
51,520 |
| 2025-07-01 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
853 |
$4.27 |
$3.64K |
52,464 |
| 2025-06-27 |
Gengos Andrew |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$3.93 |
$19.63K |
20,000 |
| 2025-06-25 |
Burroughs Amy L. |
Chief Executive Officer |
情報に基づく買い |
23,314 |
$3.87 |
$90.23K |
47,083 |
| 2025-06-16 |
Gengos Andrew |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$3.95 |
$19.73K |
15,000 |
| 2025-06-13 |
Gengos Andrew |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$3.75 |
$18.75K |
5,000 |
| 2025-06-11 |
Fellows David A |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Kindler Jeffrey B |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Turner Heather D |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Tripuraneni Radhika |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Lu Hongbo |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Quigley Jill M. |
Director |
RSU 付与（制限付株式） |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-04-01 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
952 |
$2.49 |
$2.37K |
53,317 |
| 2025-02-24 |
Gengos Andrew |
Officer |
不明 |
- |
- |
- |
- |
| 2025-02-24 |
Gengos Andrew |
Chief Financial Officer |
RSU 付与（制限付株式） |
750,000 |
$3.73 |
$2.8M |
750,000 |
| 2025-02-20 |
Azelby Robert |
Officer |
不明 |
- |
- |
- |
- |
| 2025-02-20 |
Azelby Robert |
Director |
RSU 付与（制限付株式） |
90,000 |
$4.13 |
$371.7K |
90,000 |
| 2025-02-01 |
Fellows David A |
Director |
RSU 付与（制限付株式） |
18,650 |
$4.46 |
$83.18K |
18,650 |
| 2025-02-01 |
Kindler Jeffrey B |
Director |
RSU 付与（制限付株式） |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Tripuraneni Radhika |
Director |
RSU 付与（制限付株式） |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Lu Hongbo |
Director |
RSU 付与（制限付株式） |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Quigley Jill M. |
Director |
RSU 付与（制限付株式） |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Strauss David Eric |
Principal Accounting Officer |
不明 |
60,000 |
$6.59 |
$395.4K |
- |
| 2025-01-30 |
Burroughs Amy L. |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,075,000 |
$4.64 |
$4.99M |
1,075,000 |
| 2025-01-30 |
Kuriakose Emil |
Chief Medical Officer |
RSU 付与（制限付株式） |
485,000 |
$4.64 |
$2.25M |
485,000 |
| 2025-01-30 |
Jung Melita Sun |
Chief Business Officer |
RSU 付与（制限付株式） |
325,000 |
$4.64 |
$1.51M |
325,000 |
| 2025-01-06 |
Vignola Mark J. |
Chief Financial Officer |
情報に基づく売り |
9,059 |
$5.80 |
$52.5K |
74,752 |
| 2025-01-06 |
Quigley Jill M. |
Director |
情報に基づく売り |
8,760 |
$5.79 |
$50.76K |
- |
| 2025-01-02 |
Vignola Mark J. |
Chief Financial Officer |
情報に基づく売り |
8,129 |
$5.72 |
$46.52K |
83,811 |
| 2025-01-02 |
Quigley Jill M. |
Director |
情報に基づく売り |
6,240 |
$5.72 |
$35.7K |
8,760 |
| 2025-01-02 |
Kuriakose Emil |
Chief Medical Officer |
情報に基づく売り |
4,481 |
$5.71 |
$25.61K |
54,269 |
| 2024-12-12 |
Kuriakose Emil |
Chief Medical Officer |
RSU 付与（制限付株式） |
120,000 |
$6.59 |
$790.8K |
120,000 |
| 2024-12-05 |
Burroughs Amy L. |
Chief Executive Officer |
情報に基づく買い |
15,450 |
$7.15 |
$110.47K |
19,099 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
